Are you thinking about sending your child to Camp Youngblood at Camp Holiday Trails (CHT) for the first time in 2026, have questions, or would you just like a refresher on the camp experience? Join the Hemophilia Association of the Capital Area (HACA), CHT, and VHF for a virtual information session via Zoom to learn more about Camp Youngblood – even if you aren’t quite ready to send your kids this year.
March is Bleeding Disorders Awareness Month, and in recognition of Von Willebrand Disease (VWD) Awareness Week (March 1–7), we are pleased to host the virtual educational session "Discover a New Investigational Approach to VWD Treatment" featuring Star Therapeutics. If you or someone in your family has any type of VWD or you are curious about new therapies in the bleeding disorders community, we invite you to join us for this informative and engaging session. Dr. Laura Guido, Head of Medical Affairs at Star Therapeutics.
REGISTRATION IS NOW OPEN! Annual Education Meeting: Celebrating Community and Connection. VHF’s Annual Meeting brings together individuals and families affected by inherited bleeding disorders for a weekend of education, support, and connection. This special event offers opportunities to learn about the latest in treatment and care, share experiences, and strengthen our community through networking and collaboration.
Join VABDF and CHKD for a special program designed to support families of infants and young children (age 6 and under) diagnosed with inherited bleeding disorders. This event offers an opportunity to connect with the bleeding disorders community and gain valuable education and resources. We will gather in a private meeting space for informal education, lunch, time for Q&A, networking with other parents and children, and free admission to the Virginia Zoo.
REGISTRATION IS NOW OPEN!🐞 LadyBugs Program National Conference for Women 🐞We’re proud to partner with CHES Foundation to bring you the LadyBugs Program National Conference, a national event dedicated to empowering women and girls ages 16+ impacted by bleeding disorders.